Veracyte Announces Multiple Afirma GRID Presentations at ENDO 2024, Previewing the Future of Molecular Testing in Thyroid Nodules and Cancer

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that data from three studies will demonstrate the power of the Afirma GRID (Genomic Resource for Intelligent Discovery) tool to help unlock new molecular insights into thyroid tumors, which may ultimately help to further personalize treatment of the disease. The findings will be presented at ENDO 2024, the annual meeting of The Endocrine Society, which will take place June 1-4 in Boston.

“Molecular testing in thyroid cancer currently focuses primarily on whether a patient’s thyroid nodule is benign or cancerous, and whether specific gene mutations are present,” said Joshua Klopper, M.D., Veracyte’s medical director for Endocrinology. “The data to be presented at ENDO 2024 looks beyond individual gene mutations and explores the potential of novel molecular signatures and alterations to provide more-granular, prognostic information. This may ultimately help clinicians guide more individualized care based on the molecular characteristics of each patient’s tumor. These findings are from studies using Afirma GRID, a research-use-only tool that leverages Veracyte's whole-transcriptome approach, which enables the scientific community to advance understanding of thyroid cancer biology.”

Following are details for the Afirma GRID-focused research studies that will be presented at ENDO 2024 in the Boston Convention & Exhibition Center:

Title:	Retrospective Analysis of mRNA Expression Based Signatures of Thyroid Tumor Invasion and Metastases
Presenter:	Sara Ahmadi, M.D., Brigham and Women’s Hospital
Format:	Poster Presentation (MON-640)
Time:	Monday, June 3, 2024, 12:00 p.m. - 1:30 p.m. ET
Location:	ENDO Expo Poster Area
Title:	Prostate-specific Membrane Antigen (PSMA) Expression in Cytologically Indeterminate and Malignant Thyroid Nodules
Presenter:	Rabail Sadiq, M.B.B.S., Johns Hopkins University School of Medicine